Show Summaries | Hide Summaries
We currently have no Breaking News on this stock.
IGXT vs. ETF Alternatives
IntelGenx, through its cutting edge formulation platforms, has developed a broad and diverse product portfolio, including products for the treatment of indications such as severe depression, hypertension, erectile dysfunction, migraine, insomnia, CNS indications, idiopathic pulmonary fibrosis,... More
Other News & PR